BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28729720)

  • 21. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.
    Lam LT; Davis RE; Pierce J; Hepperle M; Xu Y; Hottelet M; Nong Y; Wen D; Adams J; Dang L; Staudt LM
    Clin Cancer Res; 2005 Jan; 11(1):28-40. PubMed ID: 15671525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mucosa-associated lymphoid tissue lymphoma].
    Gong LP; Zheng J; Gao ZF
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):240-3. PubMed ID: 16776985
    [No Abstract]   [Full Text] [Related]  

  • 24. Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.
    Hatem J; Schrank-Hacker AM; Watt CD; Morrissette JJ; Rubin AI; Kim EJ; Nasta SD; Wasik MA; Bogusz AM
    Diagn Pathol; 2016 Dec; 11(1):137. PubMed ID: 27993143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular colonization of nodal marginal-zone B-cell lymphoma resembling follicular lymphoma: report of 6 cases.
    Kojima M; Nakamura S; Murase T; Motoori T; Murayama K; Iijima M; Itoh H; Sakata N; Masawa N
    Int J Surg Pathol; 2005 Jan; 13(1):73-8. PubMed ID: 15735858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
    Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
    Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.
    Li X; Xu-Monette ZY; Yi S; Dabaja BS; Manyam GC; Westin J; Fowler N; Miranda RN; Zhang M; Ferry JA; Medeiros LJ; Harris NL; Young KH
    Am J Surg Pathol; 2017 Oct; 41(10):1309-1321. PubMed ID: 28817403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular aspects of B-cell lymphomas of the gastrointestinal tract.
    Barth TF; Bentz M; Döhner H; Möller P
    Clin Lymphoma; 2001 Jun; 2(1):57-64. PubMed ID: 11707871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
    Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
    Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).
    Papaxoinis G; Papageorgiou S; Rontogianni D; Kaloutsi V; Fountzilas G; Pavlidis N; Dimopoulos M; Tsatalas C; Xiros N; Economopoulos T
    Leuk Lymphoma; 2006 Oct; 47(10):2140-6. PubMed ID: 17071488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
    Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
    Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
    Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
    Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous CD5+ marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman's disease. Case report.
    Tsukamoto N; Kojima M; Uchiyama T; Takeuchi T; Karasawa M; Murakami H; Sato S
    APMIS; 2007 Dec; 115(12):1426-31. PubMed ID: 18184415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
    Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
    J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
    de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
    Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal lymphoma: where morphology meets molecular biology.
    Isaacson PG; Du MQ
    J Pathol; 2005 Jan; 205(2):255-74. PubMed ID: 15643667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
    Lenz G; Nagel I; Siebert R; Roschke AV; Sanger W; Wright GW; Dave SS; Tan B; Zhao H; Rosenwald A; Muller-Hermelink HK; Gascoyne RD; Campo E; Jaffe ES; Smeland EB; Fisher RI; Kuehl WM; Chan WC; Staudt LM
    J Exp Med; 2007 Mar; 204(3):633-43. PubMed ID: 17353367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
    Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
    Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.
    Ramachandiran S; Adon A; Guo X; Wang Y; Wang H; Chen Z; Kowalski J; Sunay UR; Young AN; Brown T; Mar JC; Du Y; Fu H; Mann KP; Natkunam Y; Boise LH; Saavedra HI; Lossos IS; Bernal-Mizrachi L
    Int J Cancer; 2015 May; 136(10):2341-51. PubMed ID: 25359525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS].
    Škunca Z; Planinc-Peraica A
    Acta Med Croatica; 2015 Mar; 69(1):25-32. PubMed ID: 26606782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.